Adam Grimaldi, MD
Clinical Cardiac Electrophysiology · Boise, IDNPI 1730422296
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (46.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Boston Scientific at 37.0% of the total. Reporting peaked in 2020 at $13,255 and has fallen 91.3% since, to $1,150 in 2025.
Across 416 payments — averaging $60.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Abbott$7K
- Medtronic$5K
- Biosense Webster, Inc.$3K
- Cardiva Medical, Inc.$206
- Acutus Medical, Inc.$72
- plus $74 from 2 others
What the payments were for
- Grants$11,50046%
- Travel & lodging$4,27717%
- Food & beverage$9,20137%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 115 | $9,249 |
| Abbott | 13 | $6,977 |
| Medtronic(2 entities) | 217 | $5,264 |
| Biosense Webster, Inc. | 60 | $3,136 |
| Cardiva Medical, Inc. | 6 | $206 |
| Acutus Medical, Inc. | 1 | $72 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Stereotaxis Inc | 2 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$5,000
- GENERAL - THERAPIES$2,120
- Carto 3$915
- Quadra Assura CRT Defibrillator$171
- WATCHMAN FLX$148
- QDOT MICRO Catheter$139
- PulseSelect$138
How this compares
Too few clinical cardiac electrophysiology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $161,944 |
| XareltoRivaroxaban | 24 | $22,959 |
| Metoprolol Succinate | 352 | $6,733 |
| Mexiletine Hcl | 27 | $2,637 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 52 | $2,260 |
| Amiodarone Hcl | 34 | $608 |
| Carvedilol | 35 | $480 |
| Flecainide Acetate | 11 | $477 |
| Metoprolol Tartrate | 38 | $373 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Boise
- Marcos DaccarettBoise$154K
- Daniel NoonanBoise$95K
- Luciano AmadoBoise$77K
- Justice OranefoBoise$30K
- Joshua MozesBoise$26K
- Melinda MarksBoise$9K
- Petar IgicBoise$3K
- Mark RichardsPocatello$198K
- Janet OttoIdaho Falls$21K
- Michele Murphy CookCoeur D Alene$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.